NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bilihome B.V.

Bilihome B.V.

Private
NijkerkHealthcare & Life Scienceshttps://bilihome.org/

Last Round

Crowdfunding

Jul 16, 2025

Est. Valuation

$12.04M

Total Funding Raised

$2.69M

Company Overview

Bilihome B.V. is a medical technology company that develops wearable phototherapy solutions for the treatment of neonatal jaundice.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

neonatal jaundice treatmentphototherapywearable medical deviceNICU technologyhome phototherapyneonatal careremote patient monitoringRPMmedtechzero separation carebaby jaundiceblue light therapyclinical care pathwaymaternity care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bilihome B.V. Comparables

Compare Bilihome B.V. with similar companies based on industry and business-model similarity.

Bilihome B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeoMedLight
84%
NeoLight
79%
GE HealthCare Technologies Inc.
74%

Bilihome B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 16, 2025
Early FundingJan 14, 2022

Key People

Founding team and executive leadership

Margret Huenerbein

Chief Executive Officer

Executive Team

Bilihome B.V. Investors

Notable investors and investment history

Bilihome B.V. investors
InvestorRounds
NLC Health VenturesCrowdfunding
East Netherlands Development Agency (Oost NL)Early Funding, Crowdfunding
Health InnovationsEarly Funding, Crowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2022

    Secured funding from Health Innovations and Oost NL.

Bilihome B.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bilihome B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bilihome B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNijkerk
Employee Range10
Year Founded2019
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.